October 01, 2016 7:14 AM ET

Healthcare Equipment and Supplies

Company Overview of OrbusNeich Medical Company Limited

Company Overview

OrbusNeich Medical Company Limited designs, develops, manufactures, and markets medical devices for the treatment of vascular diseases. The company offers dual therapy, bare metal, pro-healing, bio-engineered R, and bio-engineered cobalt chromium stents; and other stents and balloons. It serves interventional cardiologists and physicians in Hong Kong and internationally through its predecessor companies, sales teams, and a distributor network. The company was formerly known as Neich Medical Company Limited and changed its name to OrbusNeich Medical Company Limited following its merger with Orbus Medical Technologies, Inc. in January 2005. The company was founded in 1979 and is headquartered ...

13th Floor

Harcourt House

39 Gloucester Road

Wanchai,  1102

Hong Kong

Founded in 1979


852 2802 2288


852 2507 3532

Key Executives for OrbusNeich Medical Company Limited

Chief Executive Officer, President and Director
Chairman of The Board and Executive in Charge of Asia Pacific
Age: 51
Founder, Chairman Emeritus and Director
Chief Financial Officer, Vice President and Director
Senior Vice President of Global Operation and Director
Compensation as of Fiscal Year 2016.

OrbusNeich Medical Company Limited Key Developments

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

OrbusNeich has announced that the first patient has been enrolled in the clinical study in China of its COMBO™ Dual Therapy Stent. The China Recovery Study is designed to evaluate the COMBO Dual Therapy Stent compared to the Nano stent (Lepu Medical Technology Co, Ltd). The first patient was enrolled by Dr. Yuan Ming at The First Affiliated Hospital of the Fourth Military Medical University in May 2015. The study, a multi-center, prospective, non-inferiority, randomized controlled trial, will enroll 436 patients at up to 20 hospitals throughout China. The study will enroll patients with de novo stenotic lesions in native coronary arteries. Patients will be randomized 1:1 to the COMBO Dual Therapy Stent or the Nano stent, with follow up at 30 days, 6 months, 12 months and annually for up to 5 years. Additionally, Angiographic follow-up will be performed for all subjects at 9 months post-procedure. The principal investigator is Professor Tao Ling from the First Affiliated Hospital of the Fourth Military Medical University, Xian, China.

Orbusneich Appoints Ricky Kwan as Vice President, Asia Pacific Sales

OrbusNeich announced the appointment of Ricky Kwan to the role of Vice President, Asia Pacific Sales. With an outstanding 22-year career in medical sales and product management, having served most recently as Program Director at Biotronik, Mr. Kwan possesses vast experience in cardiovascular device sales management. Mr. Kwan will be based in Singapore and will report directly to Alain Aimonetti, Senior Vice President, Global Sales and Marketing.

OrbusNeich Appoints Alain Aimonetti as Vice President Global Marketing and Sales EMEA

OrbusNeich announced the appointment of Alain Aimonetti as Vice President Global Marketing and Sales EMEA. Mr. Aimonetti will focus on the company's extensive portfolio of high-performance stents and balloons, including the COMBOTM Dual Therapy Stent - the world's first dual therapy stent, launched in 2013. His most recent position was at Biotronik where he was VP Global Sales and Business Development, Vascular Intervention.

Similar Private Companies By Industry

Company Name Region
A&B (HK) Company Limited Asia
Bioland Technology Ltd. Asia
DIH International Limited Asia
EcoGlove Ltd. Asia
Global System Limited Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OrbusNeich Medical Company Limited, please visit www.orbusneich.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.